Medical News

---

• Collateral flow effect on stroke risk modified by stenosis severity
• Impulse control disorders common in BD patients
• Substance abuse ‘does not explain homicidal violence in schizophrenia’
• Novel method developed for detecting FH mutations
• <i>SREBP-1</i> gene variant linked to hypolipidemia
• Novel macrophage biomarker predicts heart failure hospitalizations
• AMI outcomes improving among younger patients
• Statin benefits similar in patients with diabetes or the metabolic syndrome
• Australian children need to consume more n-3 fatty acids
• <i>APOE</i> variation linked to longevity
• Statin benefits similar in patients with diabetes or the metabolic syndrome
• Insulin, glucagon release ‘deranged’ in diabetics
• ‘Poor’ disease control and QoL in geriatric diabetics
• Statin benefits similar in patients with diabetes or the metabolic syndrome
• Olive oil consumption ‘protective’ against stroke
• CONSCIOUS-2 publication confirms lack of clazosentan benefits

Collateral flow effect on stroke risk modified by stenosis severity Posted: 20 Jun 2011 05:00 PM PDT The presence of collateral blood flow modifies patients' stroke risk differently according to the severity of intracranial atherosclerosis, shows an analysis of the WASID trial.

Impulse control disorders common in BD patients Posted: 20 Jun 2011 05:00 PM PDT Around a quarter of patients with bipolar disorder also have an impulse control disorder, results from a Turkish study suggest.

Substance abuse ‘does not explain homicidal violence in schizophrenia’ Posted: 20 Jun 2011 05:00 PM PDT Comorbid substance abuse and a history of criminal behaviour do not explain increased rates of homicidal violence in patients with schizophrenia, say Australian researchers.

Novel method developed for detecting FH mutations Posted: 20 Jun 2011 05:00 PM PDT Taiwanese researchers have developed a high-throughput DNA resequencing array that accurately and efficiently identifies disease-causing mutations in patients with familial hypercholesterolemia.

<i>SREBP-1</i> gene variant linked to hypolipidemia Posted: 20 Jun 2011 05:00 PM PDT Researchers have identified a gene mutation that appears to contribute to a novel form of severe combined hypolipidemia.

Novel macrophage biomarker predicts heart failure hospitalizations Posted: 20 Jun 2011 05:00 PM PDT MedWire News: Levels of a novel marker of macrophage/monocyte activation is not only an independent predictor of hospitalization for heart failure, but also improves the risk prediction of models using conventional biomarkers, study findings indicate.

AMI outcomes improving among younger patients Posted: 20 Jun 2011 05:00 PM PDT The risk for death and heart failure in young patients hospitalized with acute myocardial infarction patients has decreased over the past three decades, despite risk factors and comorbidities having become more common, say US researchers.

Statin benefits similar in patients with diabetes or the metabolic syndrome Posted: 19 Jun 2011 05:00 PM PDT The effect of statin therapy in reducing recurrent stroke and cardiovascular event risk is similar for patients with Type 2 diabetes and the metabolic syndrome, secondary analysis of data from the SPARCL trial suggests.

Australian children need to consume more n-3 fatty acids Posted: 19 Jun 2011 05:00 PM PDT Many Australian children are not consuming enough long chain n-3 polyunsaturated fatty acids for optimal health, study findings suggest.

<i>APOE</i> variation linked to longevity Posted: 19 Jun 2011 05:00 PM PDT Variations in the apolipoprotein E gene are associated with human longevity, study results suggest.

Statin benefits similar in patients with diabetes or the metabolic syndrome Posted: 19 Jun 2011 05:00 PM PDT The effect of statin therapy in reducing recurrent stroke and cardiovascular event risk is similar for patients with Type 2 diabetes and the metabolic syndrome, secondary analysis of data from the SPARCL trial suggests.

Insulin, glucagon release ‘deranged’ in diabetics Posted: 19 Jun 2011 05:00 PM PDT Researchers have found that the relationship between insulin and glucagon may be disrupted in patients with Type 2 diabetes.

‘Poor’ disease control and QoL in geriatric diabetics Posted: 19 Jun 2011 05:00 PM PDT Geriatric patients with Type 2 diabetes have a poor quality of life, an insufficient level of glucose control, and an increased frequency of comorbidities, researchers report.

Statin benefits similar in patients with diabetes or the metabolic syndrome Posted: 19 Jun 2011 05:00 PM PDT The effect of statin therapy in reducing recurrent stroke and cardiovascular event risk is similar for patients with Type 2 diabetes and the metabolic syndrome, secondary analysis of data from the SPARCL trial suggests.

Olive oil consumption ‘protective’ against stroke Posted: 16 Jun 2011 05:00 PM PDT Increased intake of olive oil is associated with a reduced risk for stroke, findings from a population-based study suggest.

CONSCIOUS-2 publication confirms lack of clazosentan benefits Posted: 15 Jun 2011 05:00 PM PDT Publication of the CONSCIOUS-2 trial confirms a lack of morbidity and mortality benefits in patients with aneurysmal subarachnoid hemorrhage given clazosentan to prevent vasospasm after surgical clipping.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610